Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, especially for cancers where cure options remain limited. Make use of the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/sedas-flagship-verification-module-to-secure-a-120-billion-industry/